Prices delayed by at least 15 minutes | Print


DRI HEALTHCARE TRUST (DHT.UN)

Equity
Sell: 14.71 CAD|Buy: 15 CAD|Change: 0.14 (-0.93%)

Open 

15.03 CAD


Previous close 

15.02 CAD


Trade high 

15.04 CAD


Volume 

22,653


Year high 

17.43 CAD


Year low 

9.10 CAD


Dividend yield 

2.8%


Market capitalisation 

838.61 mn CAD


P/E ratio 

5.52


ISIN 

CA23344H1091


This share can be held in a Dealing accountSIPP

Share price

Performance 15/05/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
DRI HEALTHCARE TRUST- 0.93
More...

Company profile

DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines thathave a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, primarily focused on acquiring royalty assets. Geographically the trust generates major revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.